kabutan

Fuso Pharma, 13% Decrease in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 8 yen

Fri May 9, 2025 1:40 pm JST Earnings

4538 Fuso Pharmaceutical Industries,Ltd. 【J-GAAP】

Earnings Report

Fuso Pharmaceutical Industries,Ltd. <4538> [TSE Prime] announced its financial results in the afternoon session on May 9th (13:40). The ordinary profit (non-consolidated) for the fiscal year ending March 2025 expanded 2.0 times that of the previous period to 3.78 billion yen. However, for the fiscal year ending March 2026, the ordinary profit is expected to decrease by 12.7% from the previous period to 3.3 billion yen.

At the same time, the company has decided to increase the dividend this fiscal year to 90 yen, an increase of 8 yen from the previous fiscal year.

In the most recent three-month period, from January to March (4Q), the ordinary profit surged 11 times that of the same period last year, reaching 0.43 billion yen. The operating profit margin improved from 1.0% in the same period last year to 3.6%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 51,015 2,206 2,215 1,605 183.1 70 May 10, 2023 J-GAAP
Mar, 2024 55,407 1,964 1,868 1,377 160.0 70 May 10, 2024 J-GAAP
Mar, 2025 60,563 4,131 3,780 -3,288 -385.0 82 May 9, 2025 J-GAAP
YoY +9.3% +110.3% +102.4% － －

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Guidance 60,000 4,000 3,700 2,600 304.4 82 Nov 11, 2024 J-GAAP
Mar, 2025 Results 60,563 4,131 3,780 -3,288 -385.0 82 May 9, 2025 J-GAAP
Revision Rate +0.9% +3.3% +2.2% － －

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 29,739 2,434 2,143 1,535 179.8 40 Nov 11, 2024 J-GAAP
Apr - Sep, 2025 Guidance 30,600 1,600 1,600 1,100 128.8 45 May 9, 2025 J-GAAP
YoY +2.9% -34.3% -25.3% -28.3% -28.3%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 55,407 1,964 1,868 1,377 160.0 70 May 10, 2024 J-GAAP
Mar, 2025 60,563 4,131 3,780 -3,288 -385.0 82 May 9, 2025 J-GAAP
Mar, 2026 Guidance 61,500 3,400 3,300 2,300 269.4 90 May 9, 2025 J-GAAP
YoY +1.5% -17.7% -12.7% － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2024 12,577 121 39 150 17.4 1.0 May 10, 2024 J-GAAP
Apr - Jun, 2024 14,622 1,150 909 632 74.1 7.9 Aug 8, 2024 J-GAAP
Jul - Sep, 2024 15,117 1,284 1,234 903 105.7 8.5 Nov 11, 2024 J-GAAP
Oct - Dec, 2024 16,920 1,199 1,198 867 101.5 7.1 Feb 10, 2025 J-GAAP
Jan - Mar, 2025 13,904 498 439 -5,690 -666.2 3.6 May 9, 2025 J-GAAP
YoY +10.6% +311.6% +1,025.6% － －

Related Articles